Given the morbidity associated with<unk> , and the high cost of  HRT and non- hormonal therapy, current pharmacotherapy to treat<unk>  are cost-effective.
Menopause cost-effectiveness of therapy
Hirsutism cost-effectiveness of therapy
Delayed puberty cost-effectiveness of therapy
Tamoxifen detailed information
Osteoporosis cost-effectiveness of therapy
Ovarian cancer cost-effectiveness of therapy
Dysfunctional uterine bleeding cost-effectiveness of therapy
Anhedonia cost-effectiveness of therapy